Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
M-701 by Wuhan YZY Biopharma for Malignant Ascites: Likelihood of Approval
M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Malignant Ascites. According to GlobalData,...
M-701 by Wuhan YZY Biopharma for Malignant Pleural Effusion: Likelihood of Approval
M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Malignant Pleural Effusion. According to...
M-701 by Wuhan YZY Biopharma for Ovarian Cancer: Likelihood of Approval
M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase III for Ovarian Cancer. According to GlobalData,...